Small-Molecule Composition for Induced Pluripotent Stem Cell Chromosome Stability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing induced pluripotent stem cells increase efficiency but lack sufficient verification of safety and similarity to embryonic stem cells, leading to concerns about chromosomal stability and DNA damage during reprogramming.
Innovation Solution
A composition containing a ROCK inhibitor (thiazovivin), a MEK inhibitor (PD0325901), and an antioxidant (L-ascorbic acid) is used to treat induced pluripotent stem cells, inhibiting chromosomal structural and numerical mutations and DNA damage, thereby maintaining stability and enhancing reprogramming efficiency.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If reprogramming efficiency is increased using conventional methods, then induced pluripotent stem cells are produced more efficiently, but chromosomal stability and safety are compromised due to structural and numerical mutations
Solution Approach 1:
The patent applies parameter changes by modifying the chemical composition of the culture medium. Specifically, it replaces conventional additives (FBS, LIF, bFGF) with a defined composition containing basic fibroblast growth factor (bbFGF) at optimized concentrations (50-200 ng/mL), along with specific supplements like N2, B27, and antioxidants. This parameter optimization maintains high reprogramming efficiency while improving chromosomal stability by reducing oxidative stress and mutagenesis during induced pluripotent stem cell culture.
2Productivity
If reprogramming efficiency is increased, then more induced pluripotent stem cells are produced, but DNA damage increases during the reprogramming process
Solution Approach 1:
The patent converts the harmful effect of oxidative stress during reprogramming into a beneficial outcome by adding specific antioxidants to the culture medium. The defined composition includes antioxidants that scavenge reactive oxygen species generated during high-efficiency reprogramming, thereby protecting DNA from damage while maintaining or enhancing production efficiency. This transforms the previously harmful oxidative environment into a controlled condition that supports both high productivity and genomic integrity.
3Ease of manufacture
If conventional culture conditions are used, then induced pluripotent stem cells are easier to produce, but they differ significantly from embryonic stem cells in terms of safety and similarity
Solution Approach 1:
The patent changes the cultural parameters by implementing a fully defined medium composition that mimics embryonic stem cell culture conditions. The medium contains basic fibroblast growth factor (bbFGF) at physiological concentrations, along with optimized levels of N2, B27, and other supplements. This parameter optimization makes the culture process as easy as conventional methods while producing induced pluripotent stem cells that are significantly more similar to embryonic stem cells in terms of gene expression, epigenetic state, and chromosomal stability.
Data Source
Figure 1(a)~1(c)
Figure 2(a)~2(b)
Figure 3(a)~3(b)
AI summary
The present invention relates to a composition for maintaining the chromosome stability of pluripotent stem cells, containing a small-molecule compound and, more specifically, to a composition for maintaining the chromosome stability of induced pluripotent stem cells, containing a ROCK inhibitor, a MEK inhibitor, an ALK5 inhibitor, or an antioxidant for inhibiting structural and numerical mutations or DNA damage of the chromosomes during a step of inducing pluripotent stem cells, an inducing process, and then culturing of the induced pluripotent stem cells. The composition for maintaining the chromosome stability of induced pluripotent stem cells, containing a small-molecule compound, according to the present invention, increases the dedifferentiation rate and efficiency when the induced pluripotent stem cells are produced and has excellent effects for inhibiting structural and numeral mutations of chromosomes, and is thus very useful for developing an induced pluripotent stem cell therapeutic agent having excelling chromosome stability.